The uk's ftse 100 has experienced a mixed performance, with some reports indicating it ticked lower due to a drag from astrazeneca, while others suggest it closed higher. AstraZeneca's stock value has reportedly slumped significantly after a drug setback. The overall movement of the ftse 100 is unclear, with conflicting reports on its performance.